Expectations trend
FY2028 · fiscal year ending 2028-01-03 · fmp
BlueLinx Holdings, Inc. (BXC)
NYSEIndustrialsIndustrial - DistributionSnapshot 2026-11-04
$66.44-10.81%
Close 2026-11-05 · 1-day change
NYSEIndustrialsIndustrial - DistributionSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
2.85 → 2.85 EPS · FY ending Jan 3, 2028 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BXC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve adjusted diluted EPS of $0.21 in 2026-Q2 | Management targets adjusted EPS of $0.21 in 2026-Q2. | Intact | adjusted diluted EPS falls below $0.21 in 2026-Q2 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-01-03 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
BXC is a higher-risk industrial growth story, not a steady compounder: recent financial performance is strong, but earnings quality is fragile. Its long-term thesis is intact, though the signal has softened from favorable to mildly favorable.
BXC is expensive versus peers, with a 3.28 premium measure, while the expectations gap is negative. The valuation model has low confidence, and the evidence describes the premium as justified rather than reflecting a concentrated fragility concern.
Near term, management’s focus on specialty and structural product growth is showing results: sales and gross margin improved from the first to the second quarter of 2026. Liquidity remains strong and leverage has improved, but margin improvement is still a watch item, and the industrial sector backdrop is a headwind.
The next call is a key near-term test: a guidance cut would matter, especially given BXC’s erratic earnings surprises. Over the multi-year view, execution on profitable sales growth and margins matters, while industrial bellwethers such as GWW, FAST, and FERG may signal whether sector momentum strengthens or fades.
For the next one to three years, BXC’s thesis rests on sustaining recent sales and margin progress despite fragile earnings quality, high risk, and an expensive peer valuation. The evidence is mixed, and confidence is medium. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in BlueLinx Holdings, Inc.'s published investment case. The stated target is maintain near current margin levels. |
| Improving |
| profit margins decline significantly below recent levels |
Operating margin: 1.46% FY2026-Q3; GAAP. Published target: maintain near current margin levels. Target percentage unit is not explicit. Nov 3, 20261.459987 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain quarterly revenue near $700M | A primary condition in BlueLinx Holdings, Inc.'s published investment case. The stated target is >= $700M per quarter. | Intact | quarterly revenue falls below $700M for two consecutive quarters | Revenue: $812.61M FY2026-Q3; GAAP. Published target: >= $700M per quarter. Target period is not explicitly aligned with this observation. Nov 3, 2026812,610,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.79 → $2.85 · observed estimates
$3.23B → $3.26B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-07-25 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-07-26 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-07-27 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-07-28 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-07-29 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-07-30 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-07-31 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-08-01 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-08-02 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-08-03 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-08-04 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-08-05 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-08-06 | $1.79 | $3,228,547,000 | 1 / 3 |
| 2026-08-07 | $2.18 | $3,219,976,333 | 1 / 3 |
| 2026-08-08 | $2.18 | $3,219,976,333 | 1 / 3 |
| 2026-08-09 | $2.18 | $3,219,976,333 | 1 / 3 |
| 2026-08-10 | $2.18 | $3,219,976,333 | 1 / 3 |
| 2026-08-11 | $2.18 | $3,219,976,333 | 1 / 3 |
| 2026-08-12 | $2.18 | $3,219,976,333 | 1 / 3 |
| 2026-08-13 | $2.18 | $3,219,976,333 | 1 / 3 |
| 2026-08-14 | $2.18 | $3,219,976,333 | 1 / 3 |
| 2026-08-15 | $2.18 | $3,219,976,333 | 2 / 3 |
| 2026-08-16 | $2.18 | $3,219,976,333 | 2 / 3 |
| 2026-08-17 | $2.18 | $3,219,976,333 | 2 / 3 |
| 2026-08-18 | $2.18 | $3,219,976,333 | 2 / 3 |
| 2026-08-19 | $2.18 | $3,219,976,333 | 2 / 3 |
| 2026-08-20 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-21 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-22 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-23 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-24 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-25 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-26 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-27 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-28 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-29 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-30 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-08-31 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-01 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-02 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-03 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-04 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-05 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-06 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-07 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-08 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-09 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-10 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-11 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-12 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-13 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-14 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-15 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-16 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-17 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-18 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-19 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-20 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-21 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-22 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-23 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-24 | $2.85 | $3,273,808,667 | 2 / 3 |
| 2026-09-25 | $2.85 | $3,259,681,500 | 2 / 3 |
| 2026-09-26 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-09-27 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-09-28 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-09-29 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-09-30 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-01 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-02 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-03 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-04 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-05 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-06 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-07 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-08 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-09 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-10 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-11 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-12 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-13 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-14 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-15 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-16 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-17 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-18 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-19 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-20 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-21 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-22 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-23 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-24 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-25 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-26 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-27 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-28 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-29 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-30 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-10-31 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-11-01 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-11-02 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-11-03 | $2.85 | $3,259,681,500 | 2 / 4 |
| 2026-11-04 | $2.85 | $3,259,681,500 | 2 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.